Medexus Announces FDA Approval of GRAFAPEX (treosulfan) for Injection and Provides Business Update
GRAFAPEX™ (treosulfan) for injection is approved by the FDA for sale and use in the United States only and is not intended for export outside the United States. Medexus makes no representation that ...
FY2025 Earnings Estimate for TSE:MDP Issued By Stifel Canada
Analysts at Stifel Canada raised their FY2025 earnings estimates for Medexus Pharmaceuticals in a research note issued to ...
Medexus Pharmaceuticals (TSE:MDP) Price Target Raised to C$4.50
Medexus Pharmaceuticals (TSE:MDP – Free Report) had its price objective increased by Stifel Nicolaus from C$4.15 to C$4.50 in a research report released on Tuesday morning,BayStreet.CA reports.